Partner With Us NRI

Company details

6M Return 2.68%
1Y Return 6.41%
Mkt Cap.(Cr) 751.77
Volume 510
Div Yield 0.16%
OI Chg %
Volume 510

Open Free Demat Account Online with ICICIDIRECT


  • swot

  • technicals

  • deals

  • shareholding


Delivery and volume


  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio


Operating Profit(Cr.)

Profit after Tax(Cr.)


Reserves and Surplus



Operating Profit

Profit after tax





Equity Capital: 132.89 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 22,733.13 -38,406.68
LAST 3M 72,017.19 -50,293.88
LAST 6M 138,790.76 -188,500.14
LAST 12M 206,712.84 -177,545.72


  • About Company
  • Company Info
  • Listing Info
  • Medicamen Biotech Ltd is a widely held, Globally Recognized public limited company engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. The company is engaged in manufacture and distribution of medicines. They manufacturer and supply the range of products such as tablets, capsules, liquid syrup and dry syrup (beta lactum and non beta lactum) and ointment. The company has two manufacturing facilities namely, Bhiwadi (Rajasthan) and Haridwar (Uttarakhand). The Bhiwadi unit has ultra modern production facilities incorporating latest state of the art technology with a combination of technically qualified personnel and hardworking workforce. In Haridwar unit, the company manufactures Non-Betalactum preparations including tablets, capsules, oral liquids and ointments & creams. The company is committed to produce and provide quality medicines at competitive price for domestic as well as international markets thereby being socially responsible and rendering services to the medical Fraternity. Medicamen Biotech Ltd was incorporated on December 1993 and started their operation as distributor and manufacturer of medicines on loan license basis. The distribution activities were spread manifold over a wide market extending beyond the domestic market and started exporting to CIS countries. The vast distribution network with demand for low cost medicines prompted the company to go for own manufacturing facilities. Thus, in the year 1994, a land of 210,000 square feet in the Industrial town of Bhiwadi in the state of Rajasthan was procured. In the year 1995, the company was enlisted in Bombay Stock Exchange. In the year 2005, the company installed the second unit in the tax free zone at Haridwar in Uttarakhand, keeping the space with the ever increase in demand and fulfilling the commitment. During the year 2006-07, the company added Analgesic and Anti bacterial, Anti filarial and Anti TB products in its range and done two mega projects of Govt. of India related to Anti filarial and Anti TB drugs. They also supplied Anti bacterial products like Cotrimoxazole and Anti Analgesics like Paracetamol in bulk to their foreign partners. During the year, the company increased the production capacity of Tablets by 600 lakh Nos to 7800 lakh Nos. The second unit in Haridwar became fully operational from April 2007 with ultra modern manufacturing facilities comprises of Non Betalactum Tablets, Capsules, oral liquids & ointments with the production capacity of 4100 lakh Nos, 600 lakh Nos, 6 lakh Litre and 0.30 lakh kg respectively. The company upgraded the Bhiwadi unit with a consolidated cost of more than Rs 2.5 crore under the latest WHO guidelines on CGMP.

Read More

Registered Address

1506 Chiranjiv Tower 43, Nehru Place, New Delhi, New Delhi, 110019

Tel : 91-11-47589500
Email : cs:medicamen.com
Website : http://www.medicamen.com


Intime Spectrum Registry Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 531146
Book Closure Date (Month) : Sep
BSE Group : B
ISIN : INE646B01010

ICICIdirect Medicamen Biotech Ltd FAQ

You can buy Medicamen Biotech Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Medicamen Biotech Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 25, 2022 02:46 PM the closing price of Medicamen Biotech Ltd was ₹ 615.35.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 25, 2022 02:46 PM, the market cap of Medicamen Biotech Ltd stood at ₹ 751.77.
The latest PE ratio of Medicamen Biotech Ltd as of May 25, 2022 02:46 PM is 49.23
The latest PB ratio of Medicamen Biotech Ltd as of May 25, 2022 02:46 PM is 0.18
The 52-week high of Medicamen Biotech Ltd is ₹ 1,023.25 while the 52-week low is ₹ 495.55 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote